Transformation Capital leads spherical to scale AI-native compliance infrastructure trusted by prime Life Science and Fortune 500 firms Ketryx, the AI-powered compliance platform serving to life sciences firms ship safer merchandise quicker, at the moment introduced a $39 million Series B led by Transformation Capital, with participation from present traders together with Lightspeed Venture Partners, MIT’s E14 Fund, Ubiquity…
PurpleLab®, a healthcare analytics firm specializing in real-world knowledge, introduced it has acquired KAID Health, an AI-powered medical analytics and care administration firm. The mixture brings collectively PurpleLab’s large-scale structured claims knowledge with KAID Health’s synthetic intelligence and pure language processing know-how, making a extra full view of affected person journeys throughout structured and unstructured knowledge…
Companies Align to Advance RCM Technology and Service Excellence MedEvolve, Inc., a number one supplier of AI-driven income cycle automation and analytics expertise for healthcare organizations, at present introduced its income cycle administration (RCM) companies enterprise has been acquired by Sustainable Medical Billing, a high-performance RCM companies supplier with nationwide attain. This strategic transaction permits each…
Agent Studio marks a turning level in scientific analysis, shifting from human-heavy processes to scalable brokers that streamline work and speed up trials Medable, the main expertise supplier for scientific growth, right now launched Agent Studio: the business’s first agentic AI platform purpose-built for all times sciences. Agent Studio is a no-code agent-builder that allows scientific…
Worldwide medical imaging IT and cybersecurity firm Sectra (STO: SECT B) publicizes that Universitätsmedizin Göttingen (UMG Göttingen) in Germany will develop its enterprise imaging resolution to incorporate Sectra’s AI service, Sectra Amplifier Service. The AI service, operated inside Microsoft Azure’s public cloud atmosphere, will allow them to seamlessly combine chosen AI purposes into their scientific workflows—enhancing workflow effectivity and enhancing…
Generative AI expertise supplies healthcare organizations with stronger safety, clear visibility, and decreased handbook oversight Paubox, the main supplier of HIPAA compliant e-mail safety, at present unveiled its most bold product launch thus far—Inbound E-mail Safety, the AI-powered inbound e-mail safety resolution that improves upon rule-based filters with generative synthetic intelligence. Phishing assaults stay the…
Fujitsu immediately introduced the event of a safe and environment friendly AI agent platform to speed up operational effectivity and guarantee secure medical service provision in Japan’s healthcare sector. The brand new platform contains an orchestrator AI agent, a centralized system that helps the collaboration and coordination of a number of specialised healthcare-specific brokers developed by Fujitsu…
Well being Plans Can Entry Full RADV Audit Answer In the present day – Stay Demo at RISE West RAAPID, a number one supplier of AI-driven threat adjustment and compliance options, at the moment introduced the launch of its complete RAAPID RADV Audit Answer. This providing is particularly designed to equip well being plans with the…
CancerLinQ SmartLinQ options save time, enabling practitioners to concentrate on offering care with seamless participation in ASCO’s flagship high quality program, ASCO Licensed ConcertAI, a pacesetter in oncology generative and agentic AI SaaS and multi-modal knowledge (MMD) options for healthcare and life sciences, in the present day introduced its initiative, CancerLinQ®, is now a acknowledged high…
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a Bio-Native AI pioneer operating where TechBio meets true biological intelligence, today announced results of a newly expanded study demonstrating that its LENSai Immunogenicity Screening can reliably predict Anti-Drug-Antibody (ADA) risk for therapeutic proteins before they enter animal studies or human trials. “ADA-related failures still derail…